Treatment for Adolescent Marijuana Abuse

NCT ID: NCT00580671

Last Updated: 2015-08-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

153 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Marijuana remains the most prevalent illicit substance used by adolescents and the number of adolescents receiving treatment for marijuana abuse more than tripled during the last decade. A small number of clinical trials suggest that family-based and individual interventions have efficacy for treating adolescent substance abuse. However, even with these interventions most adolescents fail to reduce their substance use substantially, thus, there remains much room for improvement of treatment services. The overarching goal of this project is to develop and test novel behavioral treatments to enhance treatment outcome in this important treatment population, and in so doing, learn more about mechanisms of change that have broader implications for addiction science. In our initial Stage IB project "Behavioral Treatment for Adolescent Marijuana Abuse", we created, manualized, and pilot tested a unique contingency-management (CM) intervention that combined abstinence-based voucher incentives with contingency management training for parents. A small randomized, clinical trial provided encouraging results. When added to a commonly used cognitive-behavior therapy, CM improved rates of sustained abstinence during treatment. Adolescents receiving this intervention were less likely to relapse over the 9-month follow-up period, however this finding was not as robust as the observed during treatment effects, most likely due to the small sample size and associated low power to detect effects. Despite strong indicators of the efficacy of this CM intervention, there remained room for improvement in increasing rates of treatment response and reducing rates of relapse. Hypothesized mediators and moderators of change indicated that changes in parenting had direct effects on post-treatment marijuana abstinence outcomes, and that abstinence early in treatment was a robust predictor of the CM treatment effect. This proposal will systematically replicate and extend these findings. A Stage II trial will compare three treatment conditions: (1) cognitive behavior therapy (CBT only); (2) CBT plus CM; and (3) CBT plus an enhanced CM model targeting increased early abstinence rates, parenting skills, and maintenance of effects. Replicating the initial demonstration of the positive effects of CM will extend the scientific evidence for use of CM to increase treatment efficacy for substance-abusing adolescents. Testing an enhanced CM model will determine if modifications that are consistent with the underlying behavioral principles and empiricism supporting CM interventions can result in improved outcomes. Last, assessment of potential mechanisms of action, particularly parenting, adolescent psychopathology and impulsivity, will provide scientific information directly relevant to future development of more effective intervention and prevention models of adolescent substance abuse, and will inform us about fundamental mechanisms operating in drug-dependence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Marijuana Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MET/CBT+CM/BPT

Integrated psychosocial counseling. 14 weekly session. Twice weekly urine testing. Abstinence-based incentives based on urine test results. 14 weekly behavioral parenting sessions.

Group Type EXPERIMENTAL

MET/CBT

Intervention Type BEHAVIORAL

Weekly Individual Counseling Sessions

CM

Intervention Type BEHAVIORAL

Abstinence-based incentives delivered contingent on drug-negative urine test results.

BPT

Intervention Type BEHAVIORAL

Behavioral parent training involve 14 weekly counseling curriculum to improve parenting skills.

MET/CBT+CM

Integrated psychosocial counseling. 14 weekly sessions. Twice weekly urine testing. Abstinence-based incentives based on urine test results.

Group Type EXPERIMENTAL

MET/CBT

Intervention Type BEHAVIORAL

Weekly Individual Counseling Sessions

CM

Intervention Type BEHAVIORAL

Abstinence-based incentives delivered contingent on drug-negative urine test results.

MET/CBT

Integrated psychosocial counseling. 14 weekly sessions.

Group Type ACTIVE_COMPARATOR

MET/CBT

Intervention Type BEHAVIORAL

Weekly Individual Counseling Sessions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MET/CBT

Weekly Individual Counseling Sessions

Intervention Type BEHAVIORAL

CM

Abstinence-based incentives delivered contingent on drug-negative urine test results.

Intervention Type BEHAVIORAL

BPT

Behavioral parent training involve 14 weekly counseling curriculum to improve parenting skills.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 12 to 18 years old (if 18, they must attend high school and live at home)
* Report using marijuana during the previous 30 days or provide a marijuana- positive urine test
* Meet criteria for cannabis abuse or dependence
* Have a parent/guardian who can participate
* Live within a 30-minute driving range from the clinic

Exclusion Criteria

* Currently meet DSM criteria for dependence on alcohol or other illicit drugs other than marijuana (use/abuse of other drugs will not be excluded)
* Exhibit active psychosis
* Have severe medical or psychiatric illness limiting participation
* Are pregnant or breast-feeding (youth only)
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Dartmouth-Hitchcock Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alan J. Budney

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alan J Budney, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Dartmouth College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geisel School of Medicine at Dartmouth

Lebanon, New Hampshire, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Kamon J, Budney A, Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry. 2005 Jun;44(6):513-21. doi: 10.1097/01.chi.0000159949.82759.64.

Reference Type BACKGROUND
PMID: 15908833 (View on PubMed)

Stanger C, Ryan SR, Scherer EA, Norton GE, Budney AJ. Clinic- and home-based contingency management plus parent training for adolescent cannabis use disorders. J Am Acad Child Adolesc Psychiatry. 2015 Jun;54(6):445-53.e2. doi: 10.1016/j.jaac.2015.02.009. Epub 2015 Feb 28.

Reference Type DERIVED
PMID: 26004659 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5R01DA015186-07

Identifier Type: NIH

Identifier Source: secondary_id

View Link

5R01DA015186-08

Identifier Type: NIH

Identifier Source: secondary_id

View Link

75185

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Brief Intervention for Cannabis Use
NCT06395389 RECRUITING NA
Rewards for Cannabis Abstinence-study
NCT05836207 RECRUITING NA
The Teen Marijuana Check-Up
NCT00350285 COMPLETED PHASE2
Teen Marijuana Check-Up
NCT01109563 COMPLETED PHASE3
Marijuana Treatment Project - 3
NCT00107588 COMPLETED NA